OverviewSuggest Edit

Labcorp (also known as Laboratory Corporation of America Holdings) is a life sciences company that provides clinical laboratory and end-to-end drug development services. It operates through Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD) segments. The company offers a range of clinical laboratory tests used by hospitals, physicians, and other healthcare providers and commercial clients to assist in the diagnosis, monitoring, and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

TypePublic
Founded1995
HQBurlington, NC, US
Websitelabcorp.com
Overall CultureB-

Latest Updates

Employees (est.) (Dec 2020)72,400(+12%)
Job Openings1,605
Revenue (FY, 2020)$14 B(+21%)
Share Price (Jul 2021)$283.8
Cybersecurity ratingBMore

Key People/Management at Labcorp

Adam Schechter

Adam Schechter

Chairman, President, and Chief Executive Officer
Lance Berberian

Lance Berberian

Executive Vice President and Chief Information and Technology Officer
Glenn Eisenberg

Glenn Eisenberg

Executive Vice President and Chief Financial Officer
Brian Caveney

Brian Caveney

Executive Vice President, President, Diagnostics and Chief Medical Officer
Amy Summy

Amy Summy

Executive Vice President and Chief Marketing Officer
Peter J. Wilkinson

Peter J. Wilkinson

Senior Vice President and Chief Accounting Officer
Show more

Labcorp Office Locations

Labcorp has an office in Burlington
Burlington, NC, US (HQ)
531 S Spring St
Show all (1)

Labcorp Financials and Metrics

Labcorp Revenue

Embed Graph
View revenue for all periods
Labcorp's revenue was reported to be $13.98 b in FY, 2020 which is a 21% increase from the previous period.
USD

Revenue (Q1, 2021)

4.2b

Gross profit (Q1, 2021)

1.6b

Gross profit margin (Q1, 2021), %

38.4%

Net income (Q1, 2021)

770.1m

EBIT (Q1, 2021)

1.1b

Market capitalization (23-Jul-2021)

27.5b

Closing stock price (23-Jul-2021)

283.8

Cash (31-Mar-2021)

1.9b

EV

31.9b
Labcorp's current market capitalization is $27.5 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

11.3b11.6b14.0b

Revenue growth, %

2%21%

Cost of goods sold

8.2b8.3b9.0b

Gross profit

3.2b3.3b5.0b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

2.8b2.9b2.9b2.8b2.8b3.9b4.2b

Cost of goods sold

2.0b2.1b2.1b2.1b2.0b2.3b2.6b

Gross profit

789.7m824.8m817.3m728.0m760.5m1.6b1.6b

Gross profit Margin, %

28%29%28%26%27%40%38%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

426.8m337.5m1.3b

Accounts Receivable

1.5b1.5b2.5b

Prepaid Expenses

309.0m373.7m364.8m

Inventories

237.3m244.7m423.2m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

348.8m265.4m361.1m323.6m557.0m667.2m1.9b

Accounts Receivable

1.6b1.6b1.6b1.5b1.7b2.1b2.3b

Prepaid Expenses

317.1m298.6m297.7m353.2m317.5m327.2m416.8m

Inventories

233.7m219.7m234.9m254.0m342.3m392.5m427.5m
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

883.9m824.9m1.6b

Depreciation and Amortization

552.1m577.2m624.7m

Inventories

(18.9m)(21.9m)(196.6m)

Accounts Payable

43.3m(12.8m)(5.3m)
Quarterly
Show all financial metrics

Labcorp Operating Metrics

FY, 2018FY, 2019FY, 2020

Countries (Customers)

100100100

Patient Encounters per Week

2.5 m3 m3 m

Patient Encounters per Year

120 m160 m160 m

Proprietary Data Sets (Lab Test Results)

30 b35 b35 b
Show all operating metrics

Labcorp Acquisitions / Subsidiaries

Company NameDateDeal Size
Assets of Pathology, IncMarch 21, 2016
Sequenom IncJanuary 08, 2016$371 m
Covance Inc.November 03, 2014$5.6 b
1957285 Ontario Inc. dba Quality Underwriting Services
2089729 Ontario, Inc.
2248848 Ontario Inc.
3065619 Nova Scotia Company
3257959 Nova Scotia Company
896988 Ontario Limited
9279-3280 Quebec Inc.
Show more

Labcorp Revenue Breakdown

Embed Graph

Labcorp revenue breakdown by business segment: 65.5% from Labcorp Diagnostics and 34.5% from Labcorp Drug Development

Labcorp revenue breakdown by geographic segment: 10.8% from Europe, 82.5% from North America and 6.7% from Other

Human Capital Metrics

Source: www.sec.gov
Embed Graph
Show all human capital metrics

Labcorp Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

Labcorp Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Labcorp Online and Social Media Presence

Embed Graph

Labcorp Company Culture

  • Overall Culture

    B-

    78/100

  • CEO Rating

    D+

    65/100

  • Compensation

    D

    55/100

Learn more on Comparably

Labcorp News and Updates

Medical Home Network, Labcorp Collaboration Harnesses Data Analytics to Provide More Comprehensive Patient Health Picture

CHICAGO, July 8, 2021 /PRNewswire/ -- Medical Home Network (MHN) today announced a collaboration with Labcorp, a leading global life sciences company, to securely integrate lab results into patient records. The agreement will help MHN members within the Accountable Care Organization (MHN...

Labcorp Selected as a UnitedHealthcare Preferred Lab Network Provider for the Third Year in a Row

Labcorp is pleased to announce that following a rigorous quality review process, it will continue to participate as a UnitedHealthcare Preferred Laboratory Network (PLN) provider for 2021-2022. Labcorp shares a commitment to UnitedHealthcare’s Triple Aim – improving healthcare affordability, outcome…

Labcorp Launches Companion Diagnostic for Amgen’s Newly-approved Lung Cancer Therapy

Labcorp® (NYSE: LH), a leading global life sciences company, today announced the availability of therascreen® KRAS PCR Mutation Analysis, a companion diagnostic to identify patients with non-small cell lung cancer (NSCLC) who are eligible for treatment with LUMAKRAS™ (sotorasib), a new treatment opt…

Labcorp Extends COVID-19 Genomic Sequencing Work With The CDC

Labcorp (NYSE: LH), a leading global life sciences company, today announced the extension of its work with the U.S. Centers for Disease Control and Prevention (CDC) to help identify and monitor variants of SARS-CoV-2, the virus that causes COVID-19.

Labcorp and OmniSeq Launch Insight, Next-Generation Sequencing Platform to Advance Precision Oncology

Labcorp today announced the launch of OmniSeq INSIGHTsm, a comprehensive genomic and immune profiling, tissue-based test that integrates next-generation sequencing (NGS) technology. The test is designed to advance precision oncology and improve patient outcomes, as part of Labcorp’s commitment to e…

Labcorp and OmniSeq Launch Insight, Next-Generation Sequencing Platform to Advance Precision Oncology

Labcorp, a leading global life sciences company, and OmniSeq, a CAP-accredited, molecular diagnostic innovation of Roswell Park Comprehensive Cancer Center, today announced the launch of OmniSeq INSIGHTsm, a comprehensive genomic and immune profiling, tissue-based test that integrates next-generatio…
Show more

Labcorp Blogs

Coronavirus Disease (COVID-19) COVID-19 Treatment Options

Coronavirus Disease (COVID-19) COVID-19 Treatment Options stonnessen Wed, 05/26/2021 - 15:57 https://files.labcorp.com/labcorp-d8/2021-01/hero_2.jpg COVID-19 Treatment Options If you test positive for COVID-19, you have different treatment options d…

Labcorp Study Suggests COVID-19 Antibodies Remain at Least 10 Months After Infection

Labcorp Study Suggests COVID-19 Antibodies Remain at Least 10 Months After Infection dionc1 Tue, 05/25/2021 - 08:35 https://files.labcorp.com/labcorp-d8/2020-12/molecule_0.jpg Labcorp Study Suggests COVID-19 Antibodies Remain at Least 10 Months After…

Labcorp Acquires Clinical Ambulatory Business of Caromont Health

Labcorp Acquires Clinical Ambulatory Business of Caromont Health scole Fri, 05/21/2021 - 11:46 BURLINGTON, N.C., May XX, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a comprehensive labor…

Meet Prasanth, U.S. Air Force Reservist and Labcorp Oncology Head

Meet Prasanth, U.S. Air Force Reservist and Labcorp Oncology Head dionc1 Thu, 05/20/2021 - 16:31 https://files.labcorp.com/labcorp-d8/2020-12/molecule_0.jpg Unique perspectives sharpen our thinking …

A customized scaffolds approach for the detection and phasing of complex variants by next‑generation sequencing

A customized scaffolds approach for the detection and phasing of complex variants by next‑generation sequencing scole Wed, 05/19/2021 - 12:30 September 2020 Publicationhttps://files.labcorp.com/labcorp-d8/2021-05/k-Zeng-2020-CustomizedScaffoldsApproach.pdf Zsng Q, Leach NT, Zhou Z, et al.

Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity

Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity scole Wed, 05/19/2021 - 12:29 August 2020 Publicationhttps://files.labcorp.com/labcorp-d8/2021-05/h-Singh-2020-AssociationsBetweenHigh.pdf Singh K, Chandra A, Sperry T, et al.
Show more

Labcorp Frequently Asked Questions

  • When was Labcorp founded?

    Labcorp was founded in 1995.

  • Who are Labcorp key executives?

    Labcorp's key executives are Adam Schechter, Lance Berberian and Glenn Eisenberg.

  • How many employees does Labcorp have?

    Labcorp has 72,400 employees.

  • What is Labcorp revenue?

    Latest Labcorp annual revenue is $14 b.

  • What is Labcorp revenue per employee?

    Latest Labcorp revenue per employee is $193.1 k.

  • Who are Labcorp competitors?

    Competitors of Labcorp include SYNLAB International, LifeLabs and Bio-Reference Laboratories.

  • Where is Labcorp headquarters?

    Labcorp headquarters is located at 531 S Spring St, Burlington.

  • Where are Labcorp offices?

    Labcorp has an office in Burlington.

  • How many offices does Labcorp have?

    Labcorp has 1 office.